pharmacological characterization
Recently Published Documents


TOTAL DOCUMENTS

2227
(FIVE YEARS 188)

H-INDEX

97
(FIVE YEARS 6)

2022 ◽  
Author(s):  
Luis E. Gimenez ◽  
Terry A. Noblin ◽  
Savannah Y Williams ◽  
Satarupa Mullick Bagchi ◽  
Ren-Lei Ji ◽  
...  

Melanocortin peptides containing a D-naphthylalanine residue in position 7 (DNal(2')7), reported as melanocortin-3 receptor (MC3R) subtype-specific agonists in two separate publications, were found to lack significant MC3R agonist activity. The cell lines used at the University of Arizona for pharmacological characterization of these peptides, consisting of HEK293 cells stably transfected with human melanocortin receptor subtypes MC1R, MC3R, MC4R, or MC5R, were then obtained and characterized by quantitative PCR. While the MC1R cell line correctly expressed only the hMCR1, the three other cell lines were mischaracterized with regard to receptor subtype expression. Demonstration that a D-naphthylalanine residue in position 7, irrespective of the melanocortin peptide template, results primarily in antagonism of the MC3R and MC4R, then allowed us to search the published literature for additional errors. The erroneously characterized DNal(2')7-containing peptides date back to 2003; thus, our analysis suggests that systematic mischaracterization of the pharmacological properties of melanocortin peptides occurred.


2021 ◽  
Vol 201 ◽  
pp. 108818
Author(s):  
Kiran Sapkota ◽  
Erica S. Burnell ◽  
Mark W. Irvine ◽  
Guangyu Fang ◽  
Dinesh Y. Gawande ◽  
...  

2021 ◽  
pp. 174667
Author(s):  
Alexander Jackson ◽  
Eryn L. Werry ◽  
James O'Brien-Brown ◽  
Paolo Schiavini ◽  
Shane Wilkinson ◽  
...  

2021 ◽  
Vol 22 (22) ◽  
pp. 12290
Author(s):  
Sonia Maatoug ◽  
Amani Cheikh ◽  
Oussema Khamessi ◽  
Hager Tabka ◽  
Zied Landoulsi ◽  
...  

The voltage-gated K+ channels Kv3.1 display fast activation and deactivation kinetics and are known to have a crucial contribution to the fast-spiking phenotype of certain neurons. AahG50, as a natural product extracted from Androctonus australis hector venom, inhibits selectively Kv3.1 channels. In the present study, we focused on the biochemical and pharmacological characterization of the component in AahG50 scorpion venom that potently and selectively blocks the Kv3.1 channels. We used a combined optimization through advanced biochemical purification and patch-clamp screening steps to characterize the peptide in AahG50 active on Kv3.1 channels. We described the inhibitory effect of a toxin on Kv3.1 unitary current in black lipid bilayers. In silico, docking experiments are used to study the molecular details of the binding. We identified the first scorpion venom peptide inhibiting Kv3.1 current at 170 nM. This toxin is the alpha-KTx 15.1, which occludes the Kv3.1 channel pore by means of the lysine 27 lateral chain. This study highlights, for the first time, the modulation of the Kv3.1 by alpha-KTx 15.1, which could be an interesting starting compound for developing therapeutic biomolecules against Kv3.1-associated diseases.


Sign in / Sign up

Export Citation Format

Share Document